© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Amylyx Pharmaceuticals, Inc. (AMLX) shows an Average True Range (ATR) of 0.9 and an Enterprise Value of -38.53M. Its average trading volume over the past 3 months is 1.08M, indicating liquidity. These fundamental metrics provide insight into AMLX's underlying financial health and market activity.
| ATR | 0.9 |
| Enterprise Value | -38.53M |
| Avg Vol (3 Months) | 1.08M |
| Avg Vol (10 Days) | 659.08K |
Amylyx Pharmaceuticals, Inc. (AMLX) technical indicators as of May 29, 2026: the SMA 20 is 6.98%, SMA 50 at 12.3%, and SMA 200 at 39.69%. The RSI 14 value is 59.36, suggesting its current momentum. These technical analysis signals help assess AMLX's price trends and potential future movements.
| SMA 20 | 6.98% |
| SMA 50 | 12.3% |
| SMA 200 | 39.69% |
| RSI 14 | 59.36 |
Amylyx Pharmaceuticals, Inc. (AMLX) stock performance overview as of May 29, 2026: The 52-week high is $18.61 (currently -12.75% below), and the 52-week low is $4.71 (currently 486.92% above). Over the past year, AMLX's performance is 372.86%, compared to the S&P 500's 11.71% change.
| 52-Week High | 18.61 |
| 52-Week High Chg | -12.75% |
| 52-Week Low | 4.71 |
| 52-Week Low Chg | +486.92% |
| S&P 500 52-Week Chg | 11.71% |
According to market data, Amylyx Pharmaceuticals, Inc. (AMLX) stock's recent performance metrics show that over the last month, AMLX is 39.43%, with a Year-to-Date (YTD) performance of 37%. Over the past year, the stock has seen a 372.86% change. These figures summarize AMLX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 14.28 | 17.56 | 18.61 | 18.61 | 18.61 | 18.61 |
| Low | 13.19 | 12.44 | 12.44 | 10.83 | 4.71 | 10.83 |
| Performance | +33.58% | +39.43% | +10.70% | +101.58% | +372.86% | +37.00% |
According to current financial data, AMLX stock's P/E (TTM) ratio is -10.43, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for AMLX, including P/S (N/A), P/B (5.73), and P/FCF (-9.76), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | AMLX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -10.43 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 5.73 | 4.39 | 11.7 | 5.46 |
| P/FCF (TTM) | -9.76 | -7.74 | -457.32 | 30.94 |